Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Uterine Cervical Neoplasms × Injections × Clear all

Phase

Phase 2 4 Phase NA 2 Phase 1/2 2 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 21 Advanced Solid Tumors 15 Breast Neoplasms 10 Neoplasms 9 Myelodysplastic Syndromes 9 Prostatic Neoplasms 8 Advanced Solid Tumor 8 Solid Tumor 6 Recurrence 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Stomach Neoplasms 3 Solid Tumors 3 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia 3 Carcinoma, Hepatocellular 3 Primary Myelofibrosis 2 Nasopharyngeal Carcinoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Lymphoma 2 Hematologic Neoplasms 2

Interventions

Cisplatin 26 pembrolizumab 19 Brachytherapy 16 Radiotherapy 14 Carboplatin 9 Radiation 8 Platinum 7 Paclitaxel 7 1,2-diaminocyclohexaneplatinum II citrate 7 Topotecan 6 Magnetic Resonance Spectroscopy 5 Fluorodeoxyglucose F18 5 fludarabine 4 durvalumab 4 Nivolumab 4 Gemcitabine 4 Cyclophosphamide 4 Bevacizumab 4 tremelimumab 3 temsirolimus 3 atezolizumab 3 aldesleukin 3 Radiotherapy, Intensity-Modulated 3 Papillomavirus Vaccines 3 Ipilimumab 3 Interleukin-2 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Docetaxel 3 Biopsy 3 zimberelimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05475847 2022-07-28

TIL

Fudan University

Phase 1 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡